LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today it has partnered with former Major League Lacrosse (MLL) player and founder of The Face-off Academy, Greg “The Beast” Gurenlian, to provide athletes with a better treatment for turf burn through the use of NEXGEL’s Turfguard, a unique hydrogel dressing for soothing turf burn and protecting athletic wounds.
Adam Levy, CEO of NEXGEL, said, “We are thrilled to partner with Greg and his team to address the harmful effects of turf burn including, pain, infection and long-term scarring. We look forward to working with Greg and supporting him and other athletes on and off the field with Turfguard for topical recovery. NEXGEL aims to help all athletes through our gentle skin patches for treatment and protection.”
“I’ve been playing lacrosse for over 20 years and have had more than my fair share of turf burn,” said Greg Gurenlian, Founder of The Face-off Academy. “As a faceoff man, we are constantly taking a beating on our feet and off of it. I don’t know a single athlete that hasn’t dealt with turf burn at some point in their careers. The pain is one thing but dealing with the infections and long-term scarring is a huge concern. Turfguard is a medical grade response to these burns.”
Turfguard’s FDA cleared patches maintain a moist wound environment and aid in removing non-viable tissues from the wound. The patches do not pull on delicate, new or healing skin and provide an instant cooling relief to the affected area. Manufactured out of the Company’s facility in Langhorne, Pa., Turfguard is available for purchase on Amazon.com.
Greg Gurenlian is a former professional field lacrosse player from Springfield, Pennsylvania. During his lacrosse career, Gurenlian was a 6x Professional Lacrosse All-Pro, a member of the 2018 Team USA Gold Medal team and holds the U.S. record for faceoff percentage in a world game (81%). He also won the MLL MVP and the Steinfeld Trophy for winning the 2015 MLL Championship. Gurenlian retired as a member of Redwoods Lacrosse Club of the Premier Lacrosse League. He is also the founder of The Face-off Academy, a place where young players are trained in faceoffs.
Mr. Gurenlian added, “Used in hospitals for years, this is exactly what every trainer, coach and athlete needs to sooth, heal and stop infection. I’m proud to team up with Turfguard and am grateful that we could work together with Wilson Management Alliance to make this partnership happen. Lacrosse players around the country will now get a chance to see how incredibly effective Turfguard is.”
About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Forward-Looking Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "confidence," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs, such as "will," "should," "would," "may," and "could," are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise, except as required by law. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Annual Report on Form 10-K for the year ended December 31, 2021, including but not limited to the discussion under "Risk Factors" therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contacts:
Kelly Knobeck
Director of Consumer Products
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$4.74 |
Daily Change: | 0.08 1.72 |
Daily Volume: | 24,517 |
Market Cap: | US$32.180M |
November 13, 2024 November 11, 2024 October 10, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB